Search
for
Sort by
Research 121–150 of 1000+
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- Functional Interpretation of Genome-Wide Association Study Evidence in Alopecia Areata
- 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Alopecia Areata: Current and Emerging Therapies
- P64 Efficacy of baricitinib in patients with different degrees of severe alopecia areata: 52-week results from BRAVE-AA1 and BRAVE-AA2
- Alopecia areata following COVID-19 vaccine: a systematic review
- Alopecia – New building blocks
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- Advances in the mechanism and new therapies of alopecia areata
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Alopecia Areata and Systemic Lupus Erythematosus: Insights From a Nationwide Case–Control Study
- Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol
- Dissecting Cellulitis of the Scalp Successfully Treated with a Combination of Ixekizumab and Tofacitinib
- A Promising Efficacy of Tofacitinib in an Adult Patient with Alopecia Areata
- Pattern hair loss distribution: a novel presentation for alopecia areata
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Single-cell sequencing combined with spatial transcriptomics reveals the characteristics of follicle-targeted inflammation patterns in primary cicatricial alopecia
- The JAK/STAT signaling pathway: from bench to clinic
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Updates From 2021 Virtual Dermatology Nurses' Association Convention
- Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm